Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project
Open accessPublished version of a preprint
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Introduction: Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Methods: Genome Research at Fundacio ACE (GR@ACE) is a genome‐wide study of dementia and its clinical endophenotypes, defined based on AD's clinical certainty and vascular burden. We assessed the impact of known AD loci across endophenotypes to generate loci categories. We incorporated gene coexpression data and conducted pathway analysis per category. Finally, to evaluate the effect of heterogeneity in genetic studies, GR@ACE series were meta‐analyzed with additional genome‐wide association study data sets. Results: We classified known AD loci into three categories, which might reflect the disease clinical heterogeneity. Vascular processes were only detected as a causal mechanism in probable AD. The meta‐analysis strategy revealed the ANKRD31 ‐rs4704171 and NDUFAF6 ‐rs10098778 and confirmed SCIMP ‐rs7225151 and CD33 ‐rs3865444. Discussion: The regulation of vasculature is a prominent causal component of probable AD. GR@ACE meta‐analysis revealed novel AD genetic signals, strongly driven by the presence of clinical heterogeneity in the AD series.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“Highly penetrant mutations detected in families with early-onset AD have been pinpointed to three genes: APP [8], PSEN1 [9], and PSEN2 [10], leading to the establishment of the amyloid hypothesis as a potential causal mechanism for the disease [11].”
The ASA Statement on p -Values: Context, Process, and Purpose
Wasserstein, R. L., & Lazar, N. A. (2016) · The American Statistician · doi:10.1080/00031305.2016.1154108 · Cited by 6,306 · cited 2×
“Results were interpreted according to the American Statistical Association guidelines [25,26].”
InfluentialRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 2×
“Mendelian mutations of the APP gene have been found in CAA and AD [8,36].”
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 4×
“It was previously reported as a genome-wide suggestive signal by IGAP [24].”
InfluentialSelf-citationFunctional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083 · cited 1×
“As an extension of GTEx tissue eQTL mapping, we explored brain eQTLs for GWS genomic regions using additional databases available via Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA) [28].”
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 1×
“Highly penetrant mutations detected in families with early-onset AD have been pinpointed to three genes: APP [8], PSEN1 [9], and PSEN2 [10], leading to the establishment of the amyloid hypothesis as a potential causal mechanism for the disease [11].”
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“Brain autopsies have shown that roughly 80% of clinical AD patients present with brain vascular pathology [3] in addition to the common neuropathological AD hallmarks: amyloidosis, neurofibrillary tangles, and cerebral amyloid angiop-athy (CAA) [4].”
Moving to a World Beyond “ p < 0.05”
Wasserstein, R. L., Schirm, A. L., & Lazar, N. A. (2019) · The American Statistician · doi:10.1080/00031305.2019.1583913 · Cited by 2,976
Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0311-9 · Cited by 2,277 · cited 3×
“This marker is in complete linkage equilibrium with CNTNAP2-rs114360492 (r(2) 5 0), previously reported in GWAS of AD by proxy [17].”
InfluentialMachiela, M. J., & Chanock, S. J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv402 · Cited by 2,069 · cited 1×
“Markers with moderate-to-high LD (r 2 0.6) with the novel lead markers were identified using LDlink [27] for European population and were included in this analysis.”
InfluentialAnalysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924 · cited 4×
“LOAD heritability falls in the range of 13% ‒ 80% [12,13].”
InfluentialSelf-citationBaumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660 · cited 1×
“Although its incidence is decreasing due to improvements to public health systems and control of cardiovascular risk factors [1], its prevalence is steadily increasing due to rising life expectancy of human populations [2].”
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“Although both pathways have been previously associated with LOAD by network analysis [30], this is the first study to show that the association with the vascular sys-tem is conducted by AD-specific clinical subgroup.”
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
Escott-Price, V., Bellenguez, C., Wang, L.-S., Choi, S.-H., Harold, D., Jones, L., Holmans, P., Gerrish, A., Vedernikov, A., Richards, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094661 · Cited by 1,398 · cited 1×
“This region is in the close vicinity of TP53INP1 , previously associated with AD by a gene-based approach [47].”
Self-citationYoung blood reverses age-related impairments in cognitive function and synaptic plasticity in mice
Villeda, S. A., Plambeck, K. E., Middeldorp, J., Castellano, J. M., Mosher, K. I., Luo, J., Smith, L. K., Bieri, G., Lin, K., Berdnik, D., et al. (2014) · Nature Medicine · doi:10.1038/nm.3569 · Cited by 1,081 · cited 1×
“This would agree with the limited genetic correlation between neurodegenerative and other neurologic disorders [12], as well as with the re-sults obtained from heterochronic parabionts in aging models [40].”
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,012
Self-citationToledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · cited 1×
“This idea has also been claimed by others [32,33].”
Arvanitakis, Z., Capuano, A. W., Leurgans, S. E., Bennett, D. A., & Schneider, J. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30029-1 · Cited by 581
Vascular risk factors and dementia: How to move forward?
Viswanathan, A., Rocca, W. A., & Tzourio, C. (2009) · Neurology · doi:10.1212/01.wnl.0000341271.90478.8e · Cited by 414
Beecham, G. W., Hamilton, K., Naj, A. C., Martin, E. R., Huentelman, M., Myers, A. J., Corneveaux, J. J., Hardy, J., Vonsattel, J.-P., Younkin, S. G., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004606 · Cited by 343
Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies
Boyle, P. A., Yu, L., Leurgans, S. E., Wilson, R. S., Brookmeyer, R., Schneider, J. A., & Bennett, D. A. (2019) · Annals of Neurology · doi:10.1002/ana.25380 · Cited by 318
Weller, R. O., Boche, D., & Nicoll, J. A. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0498-z · Cited by 297 · cited 1×
“CAA has been proposed to compromise the perivascular drainage of A b from the brain to the peripheral system [34].”
Assessment of the genetic variance of late-onset Alzheimer's disease
Ridge, P. G., Hoyt, K. B., Boehme, K., Mukherjee, S., Crane, P. K., Haines, J. L., Mayeux, R., Farrer, L. A., Pericak-Vance, M. A., Schellenberg, G. D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.024 · Cited by 236
Transethnic genome‐wide scan identifies novel Alzheimer's disease loci
Jun, G. R., Chung, J., Mez, J., Barber, R., Beecham, G. W., Bennett, D. A., Buxbaum, J. D., Byrd, G. S., Carrasquillo, M. M., Crane, P. K., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.12.012 · Cited by 197
Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease
Broce, I. J., Tan, C. H., Fan, C. C., Jansen, I., Savage, J. E., Witoelar, A., Wen, N., Hess, C. P., Dillon, W. P., Glastonbury, C. M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1928-6 · Cited by 140 · cited 1×
“3), jointly conferred risk for AD and plasma levels of LDL [46].”
Genetics of Alzheimer's disease: recent advances
Avramopoulos, D. (2009) · Genome Medicine · doi:10.1186/gm34 · Cited by 136 · cited 1×
“LOAD heritability falls in the range of 13% ‒ 80% [12,13].”
Shared genetic contribution to ischemic stroke and Alzheimer's disease
Traylor, M., Adib‐Samii, P., Harold, D., the Alzheimer's Disease Neuroimaging Initiative, T. I. S. G. C. (., Dichgans, M., Williams, J., Lewis, C. M., Markus, H. S., & and the METASTROKE and International Genomics of Alzheimer's Project (IGAP) investigators (2016) · Annals of Neurology · doi:10.1002/ana.24621 · Cited by 71
Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35 · cited 1×
“Although APOE ε 4 was the first to be discovered and still remains the strongest genetic risk factor for AD [14], almost 40 additional genetic variants have been identified [15–17] using genome-wide association studies (GWAS) and large sequencing projects.”
Self-citation
Research works printed but not linked: 18
- 10.1212/01.wnl.0000240129.46080.53 · DOI · Paper page
- 10.1093/hmg/5.7.985 · DOI · Paper page
- Corder E., 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 8, 41
- 10.1038/s41588-019-0358-2 · DOI · Paper page
- 10.1016/j.jalz.2013.03.006 · DOI
- 10.1002/sim.973 · DOI · Paper page
- 10.1016/j.jalz.2019.01.006 · DOI
- Charidimou A., 2018, Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: the need for a balanced approach, Int J Stroke, 13, 117, 10.1177/1747493017741384 · DOI
- Sakai K., 2014, Cerebral amyloid angiopathy, Brain Nerve, 66, 827
- 10.1212/WNL.0b013e3182452b40 · DOI · Paper page
- 10.1212/NXG.0000000000000211 · DOI
- 10.1038/mp.2013.86 · DOI · Paper page
- 10.1007/s00439-016-1721-3 · DOI
- 10.1038/nature02188 · DOI · Paper page
- 10.1038/mp.2014.81 · DOI · Paper page
- Luo L., 2017, SCIMP is a transmembrane non‐TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages, Nat Commun, 8
- 10.1016/j.jneuroim.2007.09.027 · DOI
- Moreno‐Grau S., 2018, Genome‐wide significant risk factors on chromosome 19 and the APOE locus, Oncotarget, 9, 10.18632/oncotarget.25083 · DOI
Cited by
Schwartzentruber, J., Cooper, S., Liu, J. Z., Barrio-Hernandez, I., Bello, E., Kumasaka, N., Young, A. M. H., Franklin, R. J. M., Johnson, T., Estrada, K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00776-w · Cited by 532
Mechanisms of cognitive dysfunction in CKD
Viggiano, D., Wagner, C. A., Martino, G., Nedergaard, M., Zoccali, C., Unwin, R., & Capasso, G. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0266-9 · Cited by 392
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I. E., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22491-8 · Cited by 324
Self-citationMoulton, M. J., Barish, S., Ralhan, I., Chang, J., Goodman, L. D., Harland, J. G., Marcogliese, P. C., Johansson, J. O., Ioannou, M. S., & Bellen, H. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112095118 · Cited by 180
Clonal hematopoiesis is associated with protection from Alzheimer’s disease
Bouzid, H., Belk, J. A., Jan, M., Qi, Y., Sarnowski, C., Wirth, S., Ma, L., Chrostek, M. R., Ahmad, H., Nachun, D., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02397-2 · Cited by 169
Metadata
- Authors
- Moreno‐Grau, S., de Rojas, I., Hernández, I., Quintela, I., Montrreal, L., Alegret, M., Hernández‐Olasagarre, B., Madrid, L., González‐Perez, A., Maroñas, O., Rosende‐Roca, M., Mauleón, A., Vargas, L., Lafuente, A., Abdelnour, C., Rodríguez‐Gómez, O., Gil, S., Santos‐Santos, M. Á., Espinosa, A., Ortega, G., Sanabria, Á., Pérez‐Cordón, A., Cañabate, P., Moreno, M., Preckler, S., Ruiz, S., Aguilera, N., Pineda, J. A., Macías, J., Alarcón‐Martín, E., Sotolongo‐Grau, O., GR@ACE consortium, Abdelnour, C., Aguilera, N., Alarcon, E., Alegret, M., Benaque, A., Boada, M., Buendia, M., Cañabate, P., Carracedo, A., Corbatón, A., de Rojas, I., Diego, S., Espinosa, A., Gailhajenet, A., García González, P., Gil, S., Guitart, M., González Pérez, A., Hernández, I., Ibarria, M., Lafuente, A., Macias, J., Maroñas, O., Martín, E., Martínez, M. T., Marquié, M., Mauleón, A., Monté‐Rubio, G., Montrreal, L., Moreno‐Grau, S., Moreno, M., Orellana, A., Ortega, G., Pancho, A., Pelejà, E., Pérez‐Cordon, A., Pineda, J. A., Preckler, S., Quintela, I., Real, L. M., Rodríguez‐Gómez, O., Rosende‐Roca, M., Ruiz, A., Ruiz, S., Sáez, M. E., Sanabria, A., Santos‐Santos, M. A., Serrano‐Rios, M., Sotolongo‐Grau, O., Tárraga, L., Valero, S., Vargas, L., DEGESCO consortium, Adarmes‐Gómez, A. D., Alarcón‐Martín, E., Álvarez, I., Álvarez, V., Amer‐Ferrer, G., Antequera, M., Antúnez, C., Baquero, M., Bernal, M., Blesa, R., Boada, M., Buiza‐Rueda, D., Bullido, M. J., Burguera, J. A., Calero, M., Carrillo, F., Carrión‐Claro, M., Casajeros, M. J., Clarimón, J., Cruz‐Gamero, J. M., de Pancorbo, M. M., de Rojas, I., del Ser, T., Diez‐Fairen, M., Fortea, J., Franco, E., Frank‐García, A., García‐Alberca, J. M., Garcia Madrona, S., Garcia‐Ribas, G., Gómez‐Garre, P., Hernández, I., Hevilla, S., Jesús, S., Espinosa, L., Lage, C., Legaz, A., Lleó, A., López de Munáin, A., López‐García, S., Macias, D., Manzanares, S., Marín, M., Marín‐Muñoz, J., Marín, T., Marquié, M., Martín Montes, A., Martínez, B., Martínez, C., Martínez, V., Martínez‐Lage Álvarez, P., Medina, M., Mendioroz Iriarte, M., Menéndez‐González, M., Mir, P., Molinuevo, J. L., Monté‐Rubio, G., Montrreal, L., Moreno‐Grau, S., Orellana, A., Pastor, A. B., Pastor, P., Pérez Tur, J., Periñán‐Tocino, T., Piñol Ripoll, G., Rábano, A., Real de Asúa, D., Rodrigo, S., Rodríguez‐Rodríguez, E., Royo, J. L., A, R., Sanchez del Valle Díaz, R., Sánchez‐Juan, P., Sastre, I., Sotolongo‐Grau, O., Tárraga, L., Valero, S., Vicente, M. P., Vivancos, L., Initiative, A. D. N., Marquié, M., Monté‐Rubio, G., Valero, S., Benaque, A., Clarimón, J., Bullido, M. J., García‐Ribas, G., Pástor, P., Sánchez‐Juan, P., Álvarez, V., Piñol‐Ripoll, G., García‐Alberca, J. M., Royo, J. L., Franco, E., Mir, P., Calero, M., Medina, M., Rábano, A., Ávila, J., Antúnez, C., Real, L. M., Orellana, A., Carracedo, Á., Sáez, M. E., Tárraga, L., Boada, M., & Ruiz, A.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2019-08-28
- Volume
- 15
- Issue
- 10
- Pages
- 1333-1347
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2970474312
- Cited by
- 163
- References
- 33
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Instituto de Salud Carlos III
- European Commission
- European Federation of Pharmaceutical Industries and Associations
- Innovative Medicines Initiative
- European Regional Development Fund
- Alzheimer's Disease Neuroimaging Initiative
- National Institutes of Health (U01 AG024904)
- National Institute on Aging (U01‐AG032984, P50 AG016574, P30AG10161, R01 AG033193, AG081220, U01 AG032984)
- National Institute of Biomedical Imaging and Bioengineering
- Alzheimer's Association (ADGC‐10‐196728)
- Alzheimer's Drug Discovery Foundation
- BioClinica
- Biogen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Roche
- Genentech
- Fujirebio US
- GE Healthcare
- Johnson and Johnson Pharmaceutical Research and Development
- H. Lundbeck A/S
- Merck
- Meso Scale Diagnostics
- Novartis Pharmaceuticals Corporation
- Pfizer
- Servier
- Takeda Pharmaceutical Company
- Canadian Institutes of Health Research
- National Institute of Neurological Disorders and Stroke (R01 NS080820)
- CurePSP
- Mayo Foundation for Medical Education and Research
- Agencia de Innovación y Desarrollo de Andalucía
- Biomedical Research Foundation
- Center for International Business Education and Research, University of Illinois at Urbana-Champaign
- Illinois Department of Public Health
- Mayo Clinic (P50 AG16574)
- Labex
- Institut National de la Santé et de la Recherche Médicale
- Institut Pasteur
- Medical Research Council (503480)
- Wellcome Trust (082604/2/07/Z)
- Bundesministerium für Bildung und Forschung
- National Heart, Lung, and Blood Institute (R01 HL105756)
- Hjartavernd
- Erasmus Medisch Centrum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.